PAH Extension Program

PAH QuERI Extension Program Investigators' Meeting | October 18 - 20, 2018


 

 

Register Now

Thank you for confirming your availability to attend the Pulmonary Arterial Hypertension (PAH) Quality Enhancement Research Initiative (QuERI) Extension Program Investigators’ Meeting which will be hosted at the Fontainebleau Miami Beach Hotel in Miami Beach, Florida.

Please complete the Registration Form no later than Wednesday, September 12, 2018 so that we can ensure that all your travel and accommodation needs are met. Any registrations received after this date will be subject to hotel availability.

Should you have any questions or require any further information,
please do not hesitate to contact us.

Thank you in advance on behalf of the Steering Committee and our team and we very much look forward to welcoming you to Miami Beach in October.


Anatoly Langer, MD
Chair, Canadian Heart Research Centre
Professor of Medicine
University of Toronto

Vallerie V. McLaughlin, MD
Professor of Medicine; Director Pulmonary Hypertension Program, University of Michigan



PAH QuERI Extension Program Investigators' Meeting Agenda - Friday, October 19, 2018

8:00 AM Breakfast  
8:45 Welcome Vallerie V. McLaughlin, MD
Gary Palmer, MD
9:00 Update on PAH Extension Program Anatoly Langer, MD
9:30 World Symposium Changes in Classification of PAH Lewis J. Rubin, MD
9:55 Update on Risk Assessment and Treatment Vallerie V. McLaughlin, MD
10:20 Survival: Incident vs Prevalent Review Ronald J. Oudiz, MD 
10:45 Panel Discussion and Q & A All Participants / Faculty
11:05 Break  
11:25 Performance: Academic vs Community Hospitals Richard N. Channick, MD 
11:45 QuERI Methodology Update Anatoly Langer, MD
12:05 PM PH Due to Left Heart Diseases Vallerie V. McLaughlin, MD
12:30 Panel Discussion and Q & A All Participants
1:00 Lunch  
1:40 Care Gap: From PAH to PAH Extension Anatoly Langer, MD
2:00 Debate  
  -  For Optimal PAH Management Just Follow the Guidelines Richard N. Channick, MD
  - For Optimal PAH Management Start all on Triple Therapy Victor Tapson, MD
2:40 Panel Discussion and Q & A All Participants
3:00 Close  

Register Now





for more information, please click here to contact us



This program is supported by a research grant from Actelion Pharmaceuticals US. Inc
fontainebleau hotel

Fontainebleau Miami Beach Hotel
4441 Collins Ave
Miami Beach, Florida
33140 USA

> View Map

> Home
> Registration
> Schedule of Events
> Venue Information
> Important Information
> Contact Us


Project Leader

Caroline Spindler
Canadian Heart Research Centre
Tel: 1-800-659-3734 x 224
spindlerc@chrc.net

Steering Committee

Vallerie V. McLaughlin, MD (chair)
Professor of Medicine Director Pulmonary Hypertension Program
University of Michigan

Lewis J. Rubin
, MD
Emeritus Professor of Medicine
Emeritus Director, Pulmonary & Critical Care
University of California at San Diego Medical School

Richard Channick, MD
Professor of Medicine Director, Pulmonary
Hypertension Program
Massachusetts
General Hospital
Editor-in-Chief, Advances in Pulmonary Hypertension

Anatoly Langer, MD
Chair, Canadian Heart Research Centre
Professor of Medicine University of Toronto
Division of Cardiology
St. Michael’s Hospital

Ronald J. Oudiz, MD
Professor of Medicine David Geffen School of Medicine at UCLA Director, Liu Center for Pulmonary Hypertension Harbor-UCLA Medical Center

Gary Palmer, MD (non-voting)
Senior VP Medical
Actelion Pharmaceuticals US

Victor F. Tapson, MD
Director, Venous Thromboembolism and Pulmonary Vascular Disease Research Program
Director, Clinical Research, Women's Guild Lung Institute
Associate Director, Pulmonary and Critical Care Medicine
Cedars-Sinai Medical Center